









|














|
|
Calvert Management
|
Employing an impressive team of highly qualified
industry experts and staff, we provide our customers
with years of unprecedented real world experience in the
pharmaceutical and biotechnology fields.
|
|
|
Allan N. Reiss
President & Chief Executive Officer
Al is President and Chief
Executive Officer of Calvert Laboratories, Inc. He has been an active member of
the lab's management team since 2000 and is largely responsible for the complete
operations and financial activities of the
company.
Al came to Calvert following a successful international management-consulting
career that took him throughout the world and across many industry groups.
Living primarily in Florida, Al has superb weather in which to ride his custom
Black Cherry Black Pearl Harley-Davidson. Al is also an accomplished competitive
power-lifter.
|
Charles B. Spainhour, V.M.D.,
Ph.D., DABFS, DABT, DABFM
Chief Scientific Officer
Bart has complete daily operational, scientific
and regulatory responsibility for Calvert Laboratories. Dr. Spainhour has been
with Calvert Labs since Calvert Holdings acquired the Laboratory from MDS Pharma
Services in early 2000. Previously, Bart was with Pharmakon Research
International, Chrysalis International and Phoenix International Life Sciences.
Dr. Spainhour has amassed approximately thirty-eight years of experience in the
pharmaceutical industry. For his first fifteen years Bart was employed at a
company (Smith Kline & French Laboratories) that has now evolved into
GlaxoSmithKline Corp., where Bart held positions in both the research and the
development segments of the drug development timeline. Specifically, on the
research side Dr. Spainhour’s activities involved the areas of phosphodiesterase
inhibition, anti-diuretic hormone agonism and antagonism, dopamine agonism and
antagonism, neuroleptic biochemistry, anti-infective mechanisms and
structure-activity-relationships. On the development, side Bart worked in
pharmacokinetics & metabolism, radiosynthesis, process chemistry and drug safety
evaluation. Specific areas of endeavor included H2-antagonists, leukotrienes,
anti-infectives, anti-hypertensives, anti-hyperglycemic agents and anti-arrhythmics.
Dr. Spainhour has a great interest and copious amount of experience in the
research and development of natural products. Bart has also spent time as an
independent consultant in the areas of safety assessment and forensic
toxicology, held a position on the faculty at the veterinary school of Texas A &
M University and worked as a Toxicologist in other contract research
organizations.
Dr. Spainhour holds a veterinary degree from the University of Pennsylvania and
a Ph.D. from Texas A & M University (Developmental Toxicology). In his spare
time Bart enjoys gardening, photography, cabinet-making and field trial training
his Labrador Retrievers.
|
Leslie Maas
Vice President, Client
Services
Leslie Maas joined Calvert
Laboratories, Inc. (formerly Pharmakon Research) in January of 1977 as a
pharmacology technician. She became the Quality Assurance Unit Leader shortly
thereafter and was the Quality Assurance Manager from 1980-1987. She then took
the position of Manager of Client Services and Operations for 14 years.
She then became Manager of
Marketing from 2000-2003 and was promoted to Director, Client Services in 2004.
In 2006 she became Vice President, Client Services and is presently responsible
for serving the clients with information they request such as pricing,
protocols, literature, contracts and schedules of studies and also does some
project management. She keeps track of ongoing studies, inquiries and
acquisitions, does follow-up with clients. She works closely with the financial
group of Calvert on pricing and revenue recognition. She also is responsible
for preparation of exhibits at shows.
Leslie received her bachelor’s
degree in mathematics from the University of Mississippi in 1976.
Les drives around in her Alfa
Romeo in the summer. When she’s not in her Alfa she’s in her back yard
gardening. She enjoys swimming, biking, hiking and cross country skiing. If
you twist her arm she’ll even play a game of golf.
|
Jill L.
Fogleman, PH.D.
Vice President, General Toxicology
Dr. Jill (Zeiders) Fogleman joined Calvert
Laboratories, Inc. in 1999 as a Scientist/Study Director in Toxicology.
During her time at Calvert she has been responsible for directing acute and
sub-chronic toxicology studies in a variety of species, protocol development,
interaction with clients, data evaluation and report writing. She was
promoted to Associate Director of Toxicology in 2001. In this role she
oversaw the day-to-day running of the department. In addition, Jill was
also responsible for the validation and implementation of telemetry studies for
use in safety pharmacology studies. She was promoted to Vice President in
January 2006. In addition to continuing her work as a toxicology study
director she is responsible for the PK/ADME, pharmacy, and metrology departments
at Calvert.
Jill received her bachelor’s degree in biochemistry from
Susquehanna University in 1995. She then went on to graduate school at Duke
University where she received her Ph.D. in pharmacology in 1999. Her graduate
work focused on the ontogeny of cardiac
b-adrenoceptor
desensitization which resulted in four major research papers published in the
Journal of Pharmacology and Experimental Therapeutics (JPET) and the Journal of
Molecular and Cellular Cardiology.
Jill enjoys gardening, cooking and playing volleyball.
|
Darlene Gilpin, B.S., RQAP-GLP
Director, Quality Assurance
Darlene Gilpin joined Calvert
Laboratories in September, 1996 as a Research Associate in the Toxicology
department. After gaining experience at the technical level and as a report
writer, Darlene moved into the Quality Assurance Unit in 1999. In October, 2004
Darlene was promoted to Manager, Quality Assurance and in January, 2006 Darlene
was promoted to Director Quality Assurance where she is responsible for the
overall direction of the Quality Assurance Unit.
During her tenure at Calvert
Laboratories, Darlene has become an active member in the Society of Quality
Assurance (SQA), Mid-Atlantic Society of Quality Assurance (MARSQA) and the GLP
Specialty Section of SQA. In 2002, she became certified as a Registered Quality
Assurance Professional in GLP through the SQA. Darlene obtained her B.S. in
Dairy & Animal Science from the Pennsylvania State University in 1995.
|
Daniel Norton, Ph.D.
Director, Experimental Toxicology
Dan
is a native of Northeastern Pennsylvania and was a Louisiana State University
Ph.D. transplant during his graduate education where he trained as a molecular
virologist prior to coming ‘home’ to Calvert in October of 2000. Learning all
along the way as a Study Director in the toxicology department, the exposure to
the disciplines of toxicology and pharmacology have enriched his scientific
knowledge in the field of drug development. In time, opportunities to manage
departmental affairs and staff have been a welcome additional challenge to his
daily activities. Being able to work with dedicated, good people on a daily
basis is a rewarding aspect of his job.
In his spare time, spending time with family and friends and watching sports
lets him relax and keeps him grounded.
|
Steve Sloneker
Director, Pharmacokinetics & ADME
Steve Sloneker joined Calvert Laboratories, Inc.
in September of 1991 (the company was known as Pharmakon Research International
then) as a Senior Associate Scientist in the newly created department of
pharmacokinetics. Over the years to 1997, Steve became a Scientist, Study
Director, and Supervisor of the pharmacokinetic staff. In 2000, Steve was
promoted to Associate Director, Pharmacokinetics and ADME. He directs, designs,
executes, analyzes, and summarizes all aspects of preclinical pharmacokinetic
and toxicokinetic in vivo studies. He serves as a Principal Investigator
and liason for analytical services for Calvert Laboratories. In 2007, Steve was
promoted to Director. He regularly attends the annual meeting for the American
Association of Pharmaceutical Scientists and Society of Toxicology.
Steve received his bachelor’s
degree in biology from Centre College of Kentucky in 1977 and became a Graduate
Fellow in 1978 as an assistant to the Dean of Students and Science Division. In
the following years, Steve conducted research for the Tobacco and Health
Institute and College of Pharmacy at the University of Kentucky. Later, Steve
was a graduate student in the Pharmaceutical Sciences program there and
performed research and served as a teaching assistant.
Steve enjoys professional and
college sports, thoroughbred horse racing, golf, and preparing dinner for his
family.
|
Daniel Clark, A.S.
Associate Director of IT
Dan Clark
joined Calvert Laboratories, Inc. in September, 2004 as their IT Specialist. In
January, 2006 Dan was promoted to Manager of IT and then in September, 2007 he
was promoted to Associate Director of IT. Dan is responsible for maintaining
all data, network, security, and software related functions at Calvert
Laboratories, Inc.
Dan
received his Associates of Science degree in Computer Information Technology
from Johnson College, Scranton, PA in 2003 and is currently pursuing a Bachelors
degree in Computer Information Technology from the Keystone College, LaPlume,
PA. Dan is also working towards certificates for Microsoft’s MCSE.
In his spare time, Dan is
very active in coaching his sons’ baseball teams and enjoys playing softball,
golf and shooting darts with his wife and brother. |
Laurie M. Serfilippi, VMD,
DACLAM
Director of Laboratory Animal Medicine
Laurie M. Serfilippi graduated from Albright
College in 1985 magna cum laude with a BS in Biochemistry and from the
University of Pennsylvania, School of Veterinary Medicine in 1989 summa cum
laude. She became a Diplomate in the American College of Laboratory Animal
Medicine in 2005. She is licensed to practice veterinary medicine in
Pennsylvania and New York and USDA accreditated in Pennsylvania. She began her
my career in a mixed animal veterinary practice with an emphasize in bovine
medicine and surgery. She has been with the company since 1991. From 1991
until 1995 she was a subchronic/chronic toxicology study director and staff
veterinarian. From 1996 to 1998 she pursued other avenues of my career as a
veterinarian working in the pet food industry, teaching at a local veterinary
technician program and running her own equine practice. She returned to Calvert
in 1999 to the present initially as the attending veterinarian and subsequently
became the Director of Laboratory Animal Medicine.
Laurie’s primary responsibility is the health and
welfare of the animals at Calvert. This responsibility encompasses a very
diversified variety of activities such as animal welfare, care and use,
regulatory compliance, study director education, SOP development, technique
development, training, pathology and clinical pathology oversight, facility
maintenance guidance, surgical procedures, anesthesia, etc.
Extracurricular activities include church, house
building, Secretary-Treasurer for the Northeastern Pennsylvania Veterinary
Medical Association, answering employee pet related questions, cross stitching,
gardening, hiking, and bicycling.
|
Joan M. Chapdelaine, Ph.D.
Vice President, Immunology
Dr. Joan M.
Chapdelaine received her B.S. in Microbiology from the University of Rhode
Island and her Ph.D. in Genetics from the Albert Einstein College of Medicine.
After completing a Post-Doctoral fellowship in Immunology at the University of
Pennsylvania School of Medicine as a Damon Runyon-Walter Winchell Cancer Fund
Fellow, she joined the Immunology Department at Wyeth-Ayerst Research working in
the area of Immunoregulation and Rheumatoid Arthritis.
In 1988 Dr. Chapdelaine joined Calvert (formerly Pharmakon), where she
established the Immunology Department. She is currently Vice President of
Immunology and is responsible for both Immunotoxicology and Immunopharmacology.
Dr Chapdelaine has over 30 years experience in Immunology. She presently
oversees all the inflammatory/autoimmune disease models as well as studies such
as the local lymph node assay and T-dependent antibody response assay to KHL for
immunotoxicology evaluation. Dr Chapdelaine has also participated in an
Inter-laboratory evaluation of a modified Local Lymph Node Assay for the
assessment of sensitization of systemically administered test articles in which
11 different laboratories participated including the FDA.
Dr. Chapdelaine is a member of several professional organizations including the
Society of Toxicology (SOT), American College of Toxicology (ACT), American
College of Rheumatology (ACR) and the Inflammation Research Association (IRA).
She has served as a board member, secretary and registrar for the IRA.
During her free time, Joan enjoys gardening including her water garden complete
with Koi, reading, and good wine.
|
Thomas L. Ferrell, B.S.,
RLATG
Manager, Laboratory Animal Resources/Primatology
Thomas Ferrell joined Calvert (then Pharmakon) in 1996 bringing with him
over 25 years of experience in research facility management with the emphasis on
the husbandry and toxicology of nonhuman primates.
Mr. Ferrell initiated and oversees all primate activities at Calvert. In
addition he co-chairs the Institutional Animal Care and Use Committee (IACUC),
supervises Pathology activities and is the point of contact for numerous vendors and
regulatory agencies.
Active within The American Association for Laboratory Animal Science (AALAS),
Tom sits on their Editorial Review Board and serves on the faculty of The
Institute for Laboratory Animal Management.
Mr. Ferrell received his B.S. from Michigan State University and his Laboratory
Animal Technologist certification while at the U.S. Air Force School of
Aerospace Medicine.
In his spare moments, Tom has an interest in a pre-1920 classic car restoration
facility
|
|
|
calvert
holdings corporation
| copyright 2003 | all rights reserved |
|